Schedule of Warrant Activity (Details) |
8 Months Ended |
|---|---|
|
Jan. 31, 2026
USD ($)
$ / shares
shares
| |
| Share-Based Payment Arrangement [Abstract] | |
| Number of Warrants,Outstanding Balance | |
| Weighted Average Exercise Price, Outstanding Balance | $ / shares | |
| Aggregate Intrinsic Value, Outstanding Balance | $ | |
| Number of Warrants,Granted | 6,930,697 |
| Weighted Average Exercise Price, Granted | $ / shares | $ 1.46 |
| Number of Warrants,Exercised | 2,376,236 |
| Weighted Average Exercise Price, Exercised | $ / shares | $ 0 |
| Number of Warrants,Forfeited | |
| Number of Warrants,Expired | |
| Number of Warrants,Outstanding Balance | 4,554,461 |
| Weighted Average Exercise Price,Outstanding Balance | $ / shares | $ 2.22 |
| Aggregate Intrinsic Value, Exercisable Balance | $ | $ 17,786,131 |
| Number of Warrants,Exercisable Balance | 4,554,461 |
| Weighted Average Exercise Price, Exercisable Balance | $ / shares | $ 2.22 |
| X | ||||||||||
- Definition Class of warrant or right exercisable warrants or rights 1 No definition available.
|
| X | ||||||||||
- Definition Class of warrant or right weighted average exercise price exercised No definition available.
|
| X | ||||||||||
- Definition Class of warrant or right weighted average exercise price granted No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercisable number No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|